We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tiny Ultra-Flexible Endovascular Probe Records Deep-Brain Activity without Cranial Surgery

By HospiMedica International staff writers
Posted on 25 Jul 2023

Brain-Machine Interfaces (BMIs) facilitate direct electrical communication between the brain and external electronic systems, allowing brain activity to directly control devices such as prosthetics or control nerve or muscle function. More...

This is particularly helpful for those with paralysis or neurological disorders in regaining function. However, traditional BMIs are often restricted to assessing neural activity on the brain's surface. Monitoring single-neuron activity from deep brain areas usually requires invasive intracranial surgeries to embed probes, potentially leading to the risk of infection, inflammation, and damage to brain tissues. An innovative alternative involves utilizing the brain's vascular network to implant bio-probes into deep-brain regions. Researchers have now devised an ultra-small, ultra-flexible electronic neural implant that can be delivered via blood vessels and is capable of recording single-neuron activity from deep within rat brains.

Researchers at Stanford University (Stanford, CA, USA) have designed ultra-flexible micro-endovascular (MEV) probes that can be accurately delivered to deep-brain areas through the blood vessels. The researchers built a minute, flexible, mesh-like electronic recording device that can be mounted onto a flexible microcatheter and implanted into sub-100-micron scale blood vessels in the brain's inner areas. Once inserted, the device expands like a stent to record neuronal signals across the vascular wall without causing damage to the brain or its blood vessels.

To assess the potential of the MEV probe in vivo, the researchers implanted the injectable probe into the vascular system of rat brains. The MEV probe demonstrated the capability to measure local field potentials and single-neuron activity in the cortex and olfactory bulb. Furthermore, the implanted devices demonstrated long-term stability, did not cause significant changes to cerebral blood flow or rat behavior, and triggered a minimal immune response. According to the researchers, future versions of these devices could even offer customized therapies to patients by recording and decoding their neural activity, followed by delivery of the appropriate modulatory stimuli.

Related Links:
Stanford University 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Enteral Feeding Pump
Instilar 1420
New
Cervical Seal
Omni Lok
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.